Dietary Flaxseed Meal is More Protective Than Soy Protein Concentrate Against Hypertriglyceridemia and Steatosis of the Liver in an Animal Model of Obesity

REFERENCES

• Messina M, Persky V, Setchell KDR, Barnes S: Soy intake and cancer risk: a review of the in vitro and in vivo data.Nutr Cancer21 :113– 131,1994 .
   PubMed Web of Science ®Google Scholar
• Adlercreutz CHT, Golden BR, Gorbach SL, Hackerstedt KAV, Watanabe S, Hamalainen EK, Markkanen MH, Makela TH, Wahala KT, Adlercreutz T: Soybean phytoestrogen intake and cancer risk.J Nutr125(Suppl) :757S– 770S,1995 .
   Google Scholar
• Setchell KDR: Phytoestrogens: The biochemistry, physiology, and implications for human health of soy phytoestrogens.Am J Clin Nutr68 (Suppl) :1333S– 1348S,1998 .
   Google Scholar
• Messina MJ: Legumes and soybeans: overview of their nutritional profiles and health effects.Am J Clin Nutr70 (Suppl) :439S– 450S,1999 .
   Web of Science ®Google Scholar
• Anderson JW, Smith BM, Washnock CS: Cardiovascular and renal benefits of dry bean and soybean intake.Am J Clin Nutr70 (Suppl) :464S– 474S,1999 .
   Google Scholar
• Carroll KK: Review of clinical studies on cholesterol-lowering response to soy protein.J Am Diet Assoc91 :820– 827,1991 .
   PubMed Web of Science ®Google Scholar
• Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L, Clarkson TB: Dietary soy protein and estrogen replacement improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgous monkeys.Metabolism46 :698– 705,1997 .
   PubMed Web of Science ®Google Scholar
• Anderson JW, Johnstone BM, Cook-Newell ME: Meta-analysis of effects of soy protein intake on serum lipids in humans.New Engl J Med333 :276– 282,1995 .
   PubMed Web of Science ®Google Scholar
• Crouse JR, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL: A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones in plasma concentrations of lipids and lipoproteins.Arch Intern Med159 :2070– 2076,1999 .
   PubMed Web of Science ®Google Scholar
• Sugano M, Yamada Y, Yoshida K, Hashimoto Y, Matsuo T, Kimoto M: The hypocholesterolemic action of the undigested fraction of soy bean protein in rats.Atherosclerosis72 :115– 122,1988 .
   PubMed Web of Science ®Google Scholar
• Anthony MS, Clarkson TB, Waddle DL, Wolfe MS: Effects of soy protein phytoestrogens on cardiovascular risk factors in rhesus monkeys.J Nutr125(Suppl) :803S– 804S,1995 .
   Google Scholar
• Morita, T, Oh-hashi A, Takei K, Ikai M, Kasaoka S, Kiriyama S: Cholesterol-lowering effects of soybean, potato and rice proteins depend on their low methionine contents in rats fed a cholesterol-free purified diet.J Nutr127 :470– 477,1997 .
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration: Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule.Fed Regist64 :57700– 57733,1999 .
   PubMedGoogle Scholar
• Erdman JW: Soy protein and cardiovascular disease: a statement for healthcare professionals from the Nutrition committee of the AHA.Circulation102 :2555– 2559,2000 .
   PubMed Web of Science ®Google Scholar
• Ratnayake WMN, Behrens WA, Fischer PWF, L’Abbe MR, Mongeau R, Beare-Rodgers JL: Chemical and nutritional studies of flax-seed (Variety Linott) in rats.J Nutr Biochem3 :232– 240,1992 .
   Web of Science ®Google Scholar
• Prasad K: Dietary flaxseed in prevention of hypercholesterolemic atherosclerosis.Atherosclerosis132 :69– 76,1997 .
   PubMed Web of Science ®Google Scholar
• Cunnane SC, Ganguli S, Menard C, Liede AC, Hamadeh MJ, Chen ZY, Wolever TM, Jenkins DJ: High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans.Br J Nutr69 :443– 453,1994 .
   Web of Science ®Google Scholar
• Bierenbaum ML, Reichstein R, Watkins TR: Reducing atherogenic risk in hyperlipemic humans with flaxseed supplementation: a preliminary report.J Am Coll Nutr12 :501– 504,1993 .
   PubMed Web of Science ®Google Scholar
• Babu US, Mitchell GV, Wiesenfeld P, Jenkins MY, Gowda H: Nutritional and hematological impact of dietary flaxseed and defatted flaxseed meal in rats.Int J Food Sci Nutr51 :109– 117,2000 .
   PubMed Web of Science ®Google Scholar
• Michaelis OE IV, Ellwood KC, Judge JM, Schoene NW, Hansen CT: Effect of dietary sucrose on the SHR/N-corpulent rat: a new model for insulin-independent diabetes.Am J Clin Nutr39 :612– 618,1984 .
   PubMed Web of Science ®Google Scholar
• Michaelis OE IV, Patrick DH, Hansen CT, Canary JJ, Werner RM, Carswell N: Spontaneous hypertensive/NIH-corpulent rat. Animal model for insulin-independent diabetes mellitus (Type II).Am J Path123 :398– 400,1986 .
   PubMed Web of Science ®Google Scholar
• Voyles NR, Powell AM, Timmers KI, Wilkins SD, Bhathena SJ, Hansen C, Michaelis OE IV, Recant L: Reversible impairment of glucose-induced insulin secretion in SHR/N-cp rats. Genetic model of type II diabetes.Diabetes37 :398– 404,1988 .
   PubMed Web of Science ®Google Scholar
• Michaelis OE IV, Carswell N, Velasquez MT, Hansen CT: The role of obesity, hypertension, and diet in diabetes and its complication in the spontaneous hypertensive/NIH-corpulent rat.Nutrition5 :56– 59,1989 .
   PubMedGoogle Scholar
• Velasquez MT, Bhathena SJ, Hansen CT: Leptin and its relation to obesity and insulin in the SHR/N-corpulent rat, a model of type II diabetes mellitus.Int Jnl Exp Diab Res2 :217– 223,2001 .
   Google Scholar
• Andersen T, Gluud C: Liver morphology in morbid obesity: a literature study.Int J Obes8 :97– 106,1984 .
   PubMed Web of Science ®Google Scholar
• Van Steenbergen W, Lanckmans S: Liver disturbances in obesity and diabetes mellitus.Int J Obes Relat Metab Disord19 :S27– S36,1995 .
   PubMed Web of Science ®Google Scholar
• Marceau P, Biron S, Hauld FS, Marceau S, Simard S, Thung SN, Kral JG: Liver pathology and the metabolic syndrome X in severe obesity.J Clin Endocrinol Metab84 :1513– 1517,1999 .
   PubMed Web of Science ®Google Scholar
• Dixon JB, Bhathal PS, O’Brien PE: Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.Gastroenterology121 :91– 100,2001 .
   PubMed Web of Science ®Google Scholar
• Reeves PG, Nielsen FH, Fahey Jr GC: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diets.J Nutr123 :1939– 1951,1993 .
   PubMed Web of Science ®Google Scholar
• Crouse 3rd JR, Morgan T, Terry JG, Ellis J, Vitolins M, Burke GL: A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins.Arch Intern Med159 :2070– 2076,1999 .
   PubMed Web of Science ®Google Scholar
• Jenkins DJ, Kendall CW, Vidgen E, Agarwal S, Rao AV, Rosenberg RS, Diamandis EP, Novokmet R, Mehling CC, Perera T, Griffin LC, Cunnane SC: Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial.Am J Clin Nutr69 :395– 402,1999 .
   PubMed Web of Science ®Google Scholar
• Haytowitz DB, Matthews RH:“Legumes and Legume Products.” Washington DC: US Department of Agriculture, pp1– 15,1986 .
   Google Scholar
• U.S. Department of Agriculture, Nutrient Data Research Branch, Nutrition Monitoring Division:“Provisional Table on the Content of Omega-3-Fatty Acids and Other Components in Selected Foods.” Hyattsville, MD: Human Nutrition Information Service (Publication HNIS/PT-103),1988 .
   Google Scholar
• Oomah BD, Mazza G: Flaxseed proteins—A review.Food Chem48 :109– 114,1993 .
   Web of Science ®Google Scholar
• Bhatty RS: Nutrient composition of whole flaxseed and flaxseed meal. In Cunnane SC, Thompson LU (eds):“Flaxseed in Human Nutrition.” Champaign, IL: AOCS Press, pp22– 42,1995 .
   Google Scholar
• Prasad K, Mantha SV, Muir AD, Westcott ND: Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha linolenic acid.Atherosclerosis136 :367– 375,1998 .
   PubMed Web of Science ®Google Scholar
• Coward K, Barnes NC, Setchel KDR, Barnes S: Genistein and daidzein, and their a-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets.J Agric Food Chem41 :1961– 1967,1993 .
   Web of Science ®Google Scholar
• Wang H-J, Murphy PA: Isoflavone content in commercial soybean foods.J Agric Food Chem42 :1666– 1673,1994 .
   Web of Science ®Google Scholar
• Anthony MS, Clarkson TB, Hughes Jr CL, Morgan TM, Burke GL: Soy isoflavones improve cardiovascular risk factors without affecting the reproductive system of prepubertal rhesus monkeys.J Nutr126 :43– 50,1996 .
   PubMed Web of Science ®Google Scholar
• Sirtori CR, Gianazza E, Manzoni C, Lovati MR, Murphy PA: Role of isoflavones in the cholesterol reduction by soy proteins in the clinic.Am J Clin Nutr65 :166– 167,1997 .
   PubMed Web of Science ®Google Scholar
• Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC: Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not in LDL receptor-deficient mice.J Nutr128 :954– 959,1998 .
   PubMed Web of Science ®Google Scholar
• Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman Jr JW: Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women.Am J Clin Nutr68 :1375S– 1379S,1998 .
   PubMed Web of Science ®Google Scholar
• Washburn S, Burke GL, Morgan T, Anthony M: Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women.Menopause6 :7– 13,1999 .
   PubMed Web of Science ®Google Scholar
• Teixeira SR, Potter SM, Weigel R, Hannum S, Erdman Jr JW, Hasler CM: Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men.Am J Clin Nutr71 :1077– 1084,2000 .
   PubMed Web of Science ®Google Scholar
• Thompson LU, Robb P, Serraino M, Cheung F: Mammalian lignan production from various foods.Nutr Cancer16 :43– 52,1991 .
   PubMed Web of Science ®Google Scholar
• Kitts DD, Yuan YV, Wijewickreme AN, Thompson LU: Antioxidant activity of the flaxseed secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone.Mol Cell Biochem202 :91– 100,1999 .
   PubMed Web of Science ®Google Scholar
• Prasad K: Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside from flaxseed.Circulation99 :1355– 1362,1999 .
   PubMed Web of Science ®Google Scholar
• Potter S: Overview of proposed mechanisms for the hypocholesterolemic effect of soy.J Nutr125 :606S– 611S,1996 .
   Google Scholar
• Osono Y, Nakajima K, Hata Y: Hypertriglyceridemia and fatty liver: clinical diagnosis of fatty liver and lipoprotein profiles in hypertriglyceridemic patients with fatty liver.J Atheroscler Thromb2 (Suppl 1) :S47– S52,1995 .
   Google Scholar
• Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G: Fatty infiltration of liver in hyperlipidemic patients.Dig Dis Sci45 :1929– 1934,2000 .
   PubMed Web of Science ®Google Scholar
• Fong DG, Nehra V, Lindor KD, Buchman AL: Metabolic and nutritional considerations in nonalcoholic fatty liver.Hepatology32 :3– 10,2000 .
   PubMed Web of Science ®Google Scholar